Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis
Recruiting · NCT05756179 · Interventional (participants receive a specific treatment) · Lead sponsor: Alexandria University
View the official record on ClinicalTrials.gov →Interventions studied
Diosmin and Hesperidin Combination
What this trial is about
Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritis
Who can take part
Age range
19 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients with mild to moderate disease activity.
- Patient age must be more than 18 years.
Exclusion criteria
- Pregnant and lactating females.
- Patients with liver, renal impairment or any other inflammatory diseases.
- Patients on TNF-α (tumor necrosis factor- α) or IL-1β (interleukin-1β) antagonists.
Where it is running
1 location listed.
- Alexandria university hospital - Alexandria, Egypt